Omixon specializes in the analysis of targeted Next Generation Sequencing (NGS) data. Using our Target application suite we offer high resolution HLA typing. We also help scientists and clinicians to investigate challenging genomic regions such as breast cancer susceptibility genes (BRCA1 and BRCA2), cystic fibrosis gene (CFTR), as well as custom panels.
It’s a huge pleasure to announce that the Omixon Academy finally launches! This project was initiated last year based on the amazing feedback we received over our educational blog entries and decided to dedicate a whole new website to that. …more
After months of hard work, the brand new Omixon.com website is up and running. New sections such as Oncology were introduced to make sure users find what they are looking for. We hope you will like that!